IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avidity Partners Management LP

Portfolio Profile

CIK: 0001791827 | DALLAS, TX

Investment Profile

Style

Aggressive Growth

Turnover

High

Orientation

Concentrated trader
$624.4M
AUM
45
Positions
81.94%
Top 10 Conc.
95.7%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Dianthus Therapeutics Inc(DNTH)2,104,184$205.1M32.85%
2CG Oncology Inc(CGON)1,398,948$99.4M15.92%
3Oruka Therapeutics Inc(ORKA)760,424$72.4M11.59%
4Jade Biosciences Inc(JBIO)1,700,708$37.8M6.05%
5Enliven Therapeutics Inc(ELVN)550,000$27.9M4.47%

Sector Allocation

Latest filing, equity positions only

Healthcare93.77% · $585.5M
Unclassified6.14% · $38.3M
Consumer Cyclical0.09% · $591.0K

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Unclassified2.68%6.14%+3.46%
Healthcare96.81%93.77%-3.04%

AUM History

$2.5B | 83 pos.
$2.7B | 74 pos.
$3.1B | 90 pos.
$2.4B | 85 pos.
$2.0B | 81 pos.
$1.0B | 63 pos.
6
Perspective Therapeutics Inc(CATX)
6,299,999
$21.5M
3.44%
7Aktis Oncology Inc(AKTS)484,200$15.6M2.50%
8Palvella Therapeutics Inc NE(PVLA)70,000$10.7M1.71%
9Mobia MED Inc(MOBI)798,282$10.7M1.71%
10Repligen Corp(RGEN)77,800$10.6M1.70%
Consumer Defensive0.34%0%-0.34%
Consumer Cyclical0.17%0.09%-0.08%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Mid Cap56.56%53.39%-3.17%
Small Cap26.29%31.73%+5.44%
Unclassified2.68%6.14%+3.46%
Micro Cap5.64%4.55%-1.09%
Large Cap8.63%4.18%-4.45%
Mega Cap0.2%0%-0.2%
$524.7M | 67 pos.
$502.0M | 56 pos.
$439.4M | 43 pos.
$346.7M | 39 pos.
$505.3M | 52 pos.
$624.4M | 45 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

9
New
16
Closed
12
Increased
6
Decreased
18
Unchanged